SCHEMBL8207710

SCHEMBL8207710

C[C@H]1C[C@H]2[C@@H]3CC(F)C4=CC(=O)CC[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 4/20 0.54
NFKB2 Q00653 2/20 0.54
RELA Q04206 2/20 0.54
KCNH2 Q12809 1/20 0.54
HIF1A Q16665 8/20 0.45
CYP3A4 P08684 7/20 0.45
PGR P06401 6/20 0.45
AR P10275 6/20 0.45
ABCB11 O95342 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
RAB9A P51151 1/20 0.45
GAA P10253 2/20 0.43
CHRM1 P11229 1/20 0.43
TBXA2R P21731 1/20 0.43
ADRA1A P35348 1/20 0.43
FNTA P49354 1/20 0.43
FNTB P49356 1/20 0.43
NR3C1 P04150 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9619163 1.00 NFKB1 (0.54) NFKB1NFKB2RELAKCNH2HIF1A
SCHEMBL8192700 1.00 NFKB1 (0.54) NFKB1NFKB2RELAKCNH2HIF1A
SCHEMBL3083179 1.00 NFKB1 (0.54) NFKB1NFKB2RELAKCNH2HIF1A
SCHEMBL10419014 1.00 NFKB1 (0.54) NFKB1NFKB2RELAKCNH2HIF1A
SCHEMBL7565596 1.00 NFKB1 (0.54) NFKB1NFKB2RELAKCNH2HIF1A
Methyl Alcohol SCHEMBL9756756 0.99 NFKB1 (0.54) NFKB1NFKB2RELAKCNH2HIF1A
SCHEMBL8470202 0.93 NFKB1 (0.46) NFKB1NFKB2RELAKCNH2HIF1A
SCHEMBL8470203 0.93 NFKB1 (0.46) NFKB1NFKB2RELAKCNH2HIF1A
SCHEMBL2556587 0.90 NFKB1 (0.56) NFKB1NFKB2RELAKCNH2HIF1A
SCHEMBL8203795 0.89 NFKB1 (0.44) NFKB1NFKB2RELAKCNH2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1014945-A1 CATIONIC LIPID COMPOSITIONS TARGETING ANGIOGENIC ENDOTHELIAL CELLS The Regents of the University of California (US) 2000-07-05 EP disclosed
WO-1998040052-A1 CATIONIC LIPID COMPOSITIONS TARGETING ANGIOGENIC ENDOTHELIAL CELLS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-09-17 WO disclosed
US-5407926-A Administering angiostatic steroid with glucocorticoid, carrier ALCON LABORATORIES, INC. (US) 1995-04-18 US disclosed
EP-0489779-A4 OPHTHALMIC COMPOSITION 1993-01-07 EP disclosed
EP-0489779-A1 OPHTHALMIC COMPOSITION ALCON LABORATORIES, INC. (US) 1992-06-17 EP disclosed
WO-1991003245-A1 OPHTHALMIC COMPOSITION ALCON LABORATORIES, INC. (US) 1991-03-21 WO disclosed